Bio-thera Solutions
Clinical trials sponsored by Bio-thera Solutions, explained in plain language.
-
Experimental cancer drug BAT8007 safety trial halted early
Disease control TerminatedThis early-stage study tested a new drug called BAT8007 in 93 adults with advanced solid tumors that had not responded to standard treatments. The main goal was to check the drug's safety and find the right dose. The study was terminated early, so results may be limited.
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New lung cancer drug shows promise in Head-to-Head trial
Disease control TerminatedThis study tested a new drug called BAT3306 against the standard treatment Keytruda, both combined with chemotherapy, in 162 people with advanced non-small cell lung cancer. The goal was to see if BAT3306 works as well as Keytruda in shrinking tumors. The trial was stopped early,…
Phase: PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC